Related topics

CytoSorbents: 3Q Earnings Snapshot

November 6, 2018

MONMOUTH JUNCTION, N.J. (AP) _ CytoSorbents Corp. (CTSO) on Tuesday reported a loss of $3 million in its third quarter.

On a per-share basis, the Monmouth Junction, New Jersey-based company said it had a loss of 10 cents.

The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 14 cents per share.

The blood purification therapy company posted revenue of $5.7 million in the period, falling short of Street forecasts. Four analysts surveyed by Zacks expected $5.8 million.

CytoSorbents shares have increased 48 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $9.65, a climb of 50 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CTSO at https://www.zacks.com/ap/CTSO

Update hourly